Growth Metrics

Adient (ADNT) EBIT (2016 - 2025)

Adient (ADNT) has disclosed EBIT for 11 consecutive years, with $90.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 3.23% year-over-year to $90.0 million, compared with a TTM value of $112.0 million through Dec 2025, down 65.54%, and an annual FY2025 reading of $115.0 million, down 66.47% over the prior year.
  • EBIT was $90.0 million for Q4 2025 at Adient, down from $120.0 million in the prior quarter.
  • Across five years, EBIT topped out at $1.2 billion in Q3 2021 and bottomed at -$216.0 million in Q1 2025.
  • Average EBIT over 5 years is $138.7 million, with a median of $103.5 million recorded in 2023.
  • The sharpest move saw EBIT soared 2240.0% in 2021, then crashed 2800.0% in 2025.
  • Year by year, EBIT stood at $40.0 million in 2021, then soared by 185.0% to $114.0 million in 2022, then decreased by 2.63% to $111.0 million in 2023, then dropped by 16.22% to $93.0 million in 2024, then fell by 3.23% to $90.0 million in 2025.
  • Business Quant data shows EBIT for ADNT at $90.0 million in Q4 2025, $120.0 million in Q3 2025, and $118.0 million in Q2 2025.